GlaxoSmithKline plc (GSK) Given a GBX 1,850 Price Target at Berenberg Bank

GlaxoSmithKline plc (GSK) Given a GBX 1,850 Price Target at Berenberg Bank


The firm currently has a "neutral" rating on the stock. Berenberg Bank's price objective would indicate a potential upside of 19.64% from the company's current price.



from Biotech News